ALEXION PHARMACEUTICALS, INC. Insider Trading for March 2017

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in ALEXION PHARMACEUTICALS, INC..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of insider trading in ALEXION PHARMACEUTICALS, INC. for March 2017.

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Mar 29 2017	ALXN	ALEXION PHARMACEUT ...	HANTSON LUDWIG	CEO	Option Exercise	A	118.83	56,762	6,745,028	56,762
Mar 29 2017	ALXN	ALEXION PHARMACEUT ...	HANTSON LUDWIG	CEO	Grant	A	0.00	28,725	0	57,450	28.7 K to 57.5 K (+100.00 %)
Mar 06 2017	ALXN	ALEXION PHARMACEUT ...	Thiel Carsten	EVP, Chief Commerci ...	Sell	S	131.01	3,783	495,611	33,860	37.6 K to 33.9 K (-10.05 %)
Mar 06 2017	ALXN	ALEXION PHARMACEUT ...	O'Neill Julie	EVP. Global Operati ...	Sell	S	133.80	651	87,104	37,864	38.5 K to 37.9 K (-1.69 %)
Mar 01 2017	ALXN	ALEXION PHARMACEUT ...	Moriarty John B	EVP & General Couns ...	Option Exercise	A	131.25	12,800	1,680,000	12,800
Mar 01 2017	ALXN	ALEXION PHARMACEUT ...	Moriarty John B	EVP & General Couns ...	Grant	A	0.00	6,500	0	51,172	44.7 K to 51.2 K (+14.55 %)
Mar 01 2017	ALXN	ALEXION PHARMACEUT ...	Moriarty John B	EVP & General Couns ...	Sell	S	132.50	282	37,365	44,672	45 K to 44.7 K (-0.63 %)
Mar 01 2017	ALXN	ALEXION PHARMACEUT ...	Moriarty John B	EVP & General Couns ...	Sell	S	131.71	910	119,856	44,954	45.9 K to 45 K (-1.98 %)
Mar 01 2017	ALXN	ALEXION PHARMACEUT ...	Moriarty John B	EVP & General Couns ...	Sell	S	131.20	612	80,294	45,864	46.5 K to 45.9 K (-1.32 %)
Mar 01 2017	ALXN	ALEXION PHARMACEUT ...	O'Neill Julie	EVP. Global Operati ...	Option Exercise	A	131.25	14,800	1,942,500	14,800
Mar 01 2017	ALXN	ALEXION PHARMACEUT ...	O'Neill Julie	EVP. Global Operati ...	Grant	A	0.00	7,500	0	38,515	31 K to 38.5 K (+24.18 %)
Mar 01 2017	ALXN	ALEXION PHARMACEUT ...	O'Neill Julie	EVP. Global Operati ...	Sell	S	131.70	664	87,449	31,015	31.7 K to 31 K (-2.10 %)
Mar 01 2017	ALXN	ALEXION PHARMACEUT ...	O'Neill Julie	EVP. Global Operati ...	Sell	S	131.20	910	119,392	31,679	32.6 K to 31.7 K (-2.79 %)
Mar 01 2017	ALXN	ALEXION PHARMACEUT ...	Miller Edward	SVP, Chief Complian ...	Option Exercise	A	131.25	8,700	1,141,875	8,700
Mar 01 2017	ALXN	ALEXION PHARMACEUT ...	Miller Edward	SVP, Chief Complian ...	Grant	A	0.00	4,400	0	19,284	14.9 K to 19.3 K (+29.56 %)
Mar 01 2017	ALXN	ALEXION PHARMACEUT ...	Miller Edward	SVP, Chief Complian ...	Sell	S	131.70	330	43,461	14,884	15.2 K to 14.9 K (-2.17 %)
Mar 01 2017	ALXN	ALEXION PHARMACEUT ...	Miller Edward	SVP, Chief Complian ...	Sell	S	131.20	260	34,112	15,214	15.5 K to 15.2 K (-1.68 %)
Mar 01 2017	ALXN	ALEXION PHARMACEUT ...	MACKAY MARTIN	EVP & Global Head o ...	Option Exercise	A	131.25	12,800	1,680,000	12,800
Mar 01 2017	ALXN	ALEXION PHARMACEUT ...	MACKAY MARTIN	EVP & Global Head o ...	Sell	S	132.50	370	49,025	50,688	51.1 K to 50.7 K (-0.72 %)
Mar 01 2017	ALXN	ALEXION PHARMACEUT ...	MACKAY MARTIN	EVP & Global Head o ...	Grant	A	0.00	12,800	0	51,058	38.3 K to 51.1 K (+33.46 %)
Mar 01 2017	ALXN	ALEXION PHARMACEUT ...	MACKAY MARTIN	EVP & Global Head o ...	Sell	S	131.70	625	82,313	38,258	38.9 K to 38.3 K (-1.61 %)
Mar 01 2017	ALXN	ALEXION PHARMACEUT ...	MACKAY MARTIN	EVP & Global Head o ...	Sell	S	131.20	860	112,832	38,883	39.7 K to 38.9 K (-2.16 %)
Mar 01 2017	ALXN	ALEXION PHARMACEUT ...	Thiel Carsten	EVP, Chief Commerci ...	Option Exercise	A	131.25	14,800	1,942,500	29,600
Mar 01 2017	ALXN	ALEXION PHARMACEUT ...	Thiel Carsten	EVP, Chief Commerci ...	Grant	A	0.00	7,500	0	37,643	30.1 K to 37.6 K (+24.88 %)
Mar 01 2017	ALXN	ALEXION PHARMACEUT ...	Thiel Carsten	EVP, Chief Commerci ...	Sell	S	0.00	54	0	30,143	30.2 K to 30.1 K (-0.18 %)
Mar 01 2017	ALXN	ALEXION PHARMACEUT ...	Thiel Carsten	EVP, Chief Commerci ...	Sell	S	131.20	71	9,315	30,197	30.3 K to 30.2 K (-0.23 %)
Mar 01 2017	ALXN	ALEXION PHARMACEUT ...	Carmichael Clare	EVP, Chief HR Offic ...	Option Exercise	A	131.25	12,800	1,680,000	25,600
Mar 01 2017	ALXN	ALEXION PHARMACEUT ...	Carmichael Clare	EVP, Chief HR Offic ...	Sell	S	132.50	404	53,530	39,161	39.6 K to 39.2 K (-1.02 %)
Mar 01 2017	ALXN	ALEXION PHARMACEUT ...	Carmichael Clare	EVP, Chief HR Offic ...	Grant	A	0.00	6,500	0	39,565	33.1 K to 39.6 K (+19.66 %)
Mar 01 2017	ALXN	ALEXION PHARMACEUT ...	Carmichael Clare	EVP, Chief HR Offic ...	Sell	S	131.71	915	120,515	33,065	34 K to 33.1 K (-2.69 %)
Mar 01 2017	ALXN	ALEXION PHARMACEUT ...	Carmichael Clare	EVP, Chief HR Offic ...	Sell	S	131.20	860	112,832	33,980	34.8 K to 34 K (-2.47 %)
Mar 01 2017	ALXN	ALEXION PHARMACEUT ...	Wagner Heidi L	SVP, Global Governm ...	Option Exercise	A	131.25	8,700	1,141,875	8,700
Mar 01 2017	ALXN	ALEXION PHARMACEUT ...	Wagner Heidi L	SVP, Global Governm ...	Grant	A	0.00	4,400	0	33,410	29 K to 33.4 K (+15.17 %)
Mar 01 2017	ALXN	ALEXION PHARMACEUT ...	Wagner Heidi L	SVP, Global Governm ...	Sell	S	132.50	156	20,670	29,010	29.2 K to 29 K (-0.53 %)
Mar 01 2017	ALXN	ALEXION PHARMACEUT ...	Wagner Heidi L	SVP, Global Governm ...	Sell	S	131.70	480	63,216	29,166	29.6 K to 29.2 K (-1.62 %)
Mar 01 2017	ALXN	ALEXION PHARMACEUT ...	Wagner Heidi L	SVP, Global Governm ...	Sell	S	131.20	358	46,970	29,646	30 K to 29.6 K (-1.19 %)
Mar 01 2017	ALXN	ALEXION PHARMACEUT ...	BELL LEONARD	Director	Sell	S	132.50	1,240	164,300	390,670	391.9 K to 390.7 K (-0.32 %)
Mar 01 2017	ALXN	ALEXION PHARMACEUT ...	BELL LEONARD	Director	Sell	S	131.71	2,738	360,622	391,910	394.6 K to 391.9 K (-0.69 %)